CGTX

0.58223.06%
JB

John Brendan Doyle

Chief Financial Officer

Mr. John Brendan Doyle serves as Chief Financial Officer at Cognition Therapeutics, Inc. since May 2023. He served as Chief Financial Officer of 4D pharma plc since January 3, 2022 until March 2023. He served as Senior Vice President, Chief Financial Officer and Treasurer at Chiasma, Inc. since January 2021. Prior to that, Mr. Doyle served as Vice President of Finance and Investor Relations from April 2019 to December 2020 and Senior Director of Finance and Investor Relations from February 2018 to April 2019 of Verastem, Inc. Prior to joining Verastem, from May 2016 to February 2018. Prior to joining Verastem in February 2018, he served as the Head of Financial Planning and Analysis of SimpliVity Corp. From January 2015 to May 2016, he served as Director – Business Unit Financial Planning and Analysis of Early Phase Division, at Parexel, Inc. From July 2006 to January 2015, Mr. Doyle held increasingly senior financial positions with Hologic Inc. Mr. Doyle received his bachelor of science degree in finance from the University of Massachusetts.

Positions